We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

208 hedge funds and large institutions have $2.02B invested in Sabra Healthcare REIT in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 102 increasing their positions, 54 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,092% more call options, than puts

Call options by funds: $870K | Put options by funds: $73K

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

89% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 54

61% more capital invested

Capital invested by funds: $1.26B → $2.02B (+$762M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

7% more funds holding

Funds holding: 194208 (+14)

Holders
208
Holders Change
+14
Holders Change %
+7.22%
% of All Funds
6.03%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
29
Increased
102
Reduced
54
Closed
15
Calls
$870K
Puts
$73K
Net Calls
+$797K
Net Calls Change
+$797K
Name Holding Trade Value Shares
Change
Change in
Stake
PP
76
PDT Partners
New York
$2.18M +$882K +31,824 +55%
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
$2.12M +$24.8K +895 +1%
MAA
78
Managed Account Advisors
New Jersey
$2.12M -$367K -13,225 -13%
Two Sigma Investments
79
Two Sigma Investments
New York
$2.12M +$2.42M +87,118 New
NEI
80
Northwest & Ethical Investments
Ontario, Canada
$2.11M +$221K +7,979 +10%
WCM
81
Wesley Capital Management
New York
$2.09M +$541K +19,500 +29%
AAM
82
Aston Asset Management
Illinois
$2.04M -$29.3K -1,057 -1%
Legal & General Group
83
Legal & General Group
United Kingdom
$2.01M +$384K +13,841 +20%
AllianceBernstein
84
AllianceBernstein
Tennessee
$1.88M -$200K -7,200 -9%
HCM
85
Highbridge Capital Management
New York
$1.74M +$1.98M +71,525 New
PAM
86
Panagora Asset Management
Massachusetts
$1.71M +$184K +6,643 +10%
PPA
87
Parametric Portfolio Associates
Washington
$1.68M +$14.1K +510 +0.7%
FIM
88
Friedberg Investment Management
Texas
$1.53M +$381K +13,740 +28%
RA
89
RMR Advisors
Massachusetts
$1.5M
Renaissance Technologies
90
Renaissance Technologies
New York
$1.41M +$55.5K +2,000 +4%
BREA
91
Barings Real Estate Advisers
Connecticut
$1.41M +$259K +9,340 +19%
UBS AM
92
UBS AM
Illinois
$1.39M -$77.6K -2,800 -5%
LFFS
93
La Francaise Forum Securities
Connecticut
$1.33M +$514K +18,542 +51%
RhumbLine Advisers
94
RhumbLine Advisers
Massachusetts
$1.3M -$18.7K -675 -1%
Swiss National Bank
95
Swiss National Bank
Switzerland
$1.3M +$141K +5,100 +11%
Axa
96
Axa
France
$1.27M +$65.6K +2,364 +5%
AWCI
97
Alpine Woods Capital Investors
New York
$1.25M -$724K -26,096 -34%
FWCM
98
First Western Capital Management
California
$1.22M -$206K -7,439 -13%
ACPU
99
Arrowgrass Capital Partners (US)
Delaware
$1.22M +$1.39M +50,000 New
PC
100
Polar Capital
United Kingdom
$1.22M

SBRA Hedge Fund Activity: Q3 2014 in Review

208 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2014, worth a combined $2.02B — up 61% from $1.26B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SBRA positions and 15 closed out — a net gain of 14 holders — while 102 added to existing stakes and 54 trimmed.

The largest buyer was Vanguard Group, adding an estimated $22.6M. The largest seller was Bank of New York Mellon, cutting an estimated $29.8M.

  • 208 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2014, up from 194 in Q2 2014.
  • Funds reported $2.02B of Sabra Healthcare REIT stock for Q3 2014, up 61% quarter-over-quarter.
  • 29 funds opened new Sabra Healthcare REIT positions in Q3 2014 and 15 closed out, a net change of +14 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2014 was Vanguard Group, an estimated $22.6M added.
  • The largest Sabra Healthcare REIT seller in Q3 2014 was Bank of New York Mellon, an estimated $29.8M sold.

Based on aggregated 13F filings for Q3 2014.